Occudo Quantitative Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.32M Buy
7,774
+3,882
+100% +$3.97M 0.5% 40
2026
Q1
$3.64M Buy
+3,892
New +$3.95M 0.2% 152
2025
Q4
– Sell
-1,232
Closed -$940K – 822
2025
Q3
$940K Buy
+1,232
New +$917K 0.11% 255
2025
Q1
– Sell
-3,250
Closed -$2.51M – 799
2024
Q4
$2.51M Sell
3,250
-1,142
-26% -$946K 0.45% 49
2024
Q3
$3.89M Buy
+4,392
New +$3.95M 0.71% 27
2022
Q4
– Sell
-2,631
Closed -$851K – 1190
2022
Q3
$851K Sell
2,631
-2,918
-53% -$925K 0.07% 467
2022
Q2
$1.8M Buy
5,549
+3,238
+140% +$972K 0.15% 207
2022
Q1
$662K Sell
2,311
-14,369
-86% -$3.7M 0.06% 535
2021
Q4
$4.61M Sell
16,680
-1,503
-8% -$381K 0.41% 37
2021
Q3
$4.2M Buy
+18,183
New +$4.49M 0.5% 13
2021
Q2
– Sell
-1,160
Closed -$217K – 978
2021
Q1
$217K Buy
+1,160
New +$227K 0.05% 597

Other funds holding LLY

Occudo Quantitative Strategies's LLY Position: Q2 2026 in Review

Occudo Quantitative Strategies increased its Eli Lilly (LLY) stake by 100% in Q2 2026, buying an estimated $3.97M and bringing the position to 7,774 shares worth $9.32M. The position accounts for 0.5% of the portfolio, ranked #40.

Occudo Quantitative Strategies first reported a position in LLY in Q1 2021 and has held it in 11 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Occudo Quantitative Strategies held 7,774 shares of Eli Lilly worth $9.32M as of Q2 2026.
  • Occudo Quantitative Strategies bought 3,882 Eli Lilly shares in Q2 2026, an estimated $3.97M.
  • Eli Lilly made up 0.5% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #40 holding.
  • Occudo Quantitative Strategies first reported a position in Eli Lilly in Q1 2021 and has held it in 11 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.